Tarek S Ibrahim

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 43

Top Venues

Microorganisms

Pharmaceuticals (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

Molecules (Basel, Switzerland)

King Abdulaziz University Faculty of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King Abdulaziz University Faculty of Pharmacy Sep 20 2016

Saudi Arabia

Associate Professor :: Pharmaceutical Chemistry

Zagazig University Faculty of Pharmacy Dec 26 2001

Egypt

Associate Professor :: Pharmaceutical Organic Chemistry

Virginia Commonwealth University Sep 01 2014 - Mar 18 2015

United States

Post-Doc :: Department of Chemistry

University of Florida Department of Chemistry Jul 07 2009 - Nov 11 2011

United States

Ph.D. candidate / Research Affiliate :: Department of Chemistry

Publications

Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem (2024)
Mohamed Elagawany, Lina M A Abdel Ghany, Tarek S Ibrahim, Abdulrhman S Alharbi, Mohamed S Abdel-Aziz, Eman M El-Labbad, Noha Ryad
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Zuhier Ahmed Awan, Usama Ahmed Fahmy, Shaimaa M Badr-Eldin, Tarek S Ibrahim, Hani Z Asfour, Mohammed W Al-Rabia, Anas Alfarsi, Nabil Abdulhafiz Alhakamy, Wesam H Abdulaal, Hadeel Al Sadoun, Nawal Helmi, Ahmad O Noor, Filippo Caraci, Diena M Almasri, Giuseppe Caruso
RETRACTED: Awan et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 2020, 12 , 597. Pharmaceutics 16 (2) (2024)
Zuhier Ahmed Awan, Usama Ahmed Fahmy, Shaimaa M Badr-Eldin, Tarek S Ibrahim, Hani Z Asfour, Mohammed W Al-Rabia, Anas Alfarsi, Nabil Abdulhafiz Alhakamy, Wesam H Abdulaal, Hadeel Al Sadoun, Nawal Helmi, Ahmad O Noor, Filippo Caraci, Diena M Almasri, Giuseppe Caruso
RETRACTED: Awan et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 2020, 12 , 597. Pharmaceutics 16 (2) (2024)
Ehab S Taher, Adel A Marzouk, Walaa Hamada Abd-Allah, Simone Giovannuzzi, Tarek S Ibrahim, Claudiu T Supuran, Mohamed A El Hamd, Mohammed Farrag El-Behairy
Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors. ChemMedChem 19 (10) (2024)
Mohamed Elagawany, Lina M A Abdel Ghany, Tarek S Ibrahim, Abdulrhman S Alharbi, Mohamed S Abdel-Aziz, Eman M El-Labbad, Noha Ryad
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mohamed Elagawany, Lina M A Abdel Ghany, Tarek S Ibrahim, Abdulrhman S Alharbi, Mohamed S Abdel-Aziz, Eman M El-Labbad, Noha Ryad
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Mohamed Elagawany, Lina M A Abdel Ghany, Tarek S Ibrahim, Abdulrhman S Alharbi, Mohamed S Abdel-Aziz, Eman M El-Labbad, Noha Ryad
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases. Journal of enzyme inhibition and medicinal chemistry 39 (1) (2024)
Maan T Khayat, Hisham A Abbas, Tarek S Ibrahim, Samar S Elbaramawi, Ahdab N Khayyat, Majed Alharbi, Wael A H Hegazy, Fatma Al-Zahraa A Yehia
Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems. Biomedicines 11 (5) (2023)
Mohamed S Attia, Mohamed F Radwan, Tarek S Ibrahim, Tarek M Ibrahim
Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance. Pharmaceutics 15 (5) (2023)
Ahmad J Almalki, Tarek S Ibrahim, Sameh S Elhady, Khaled M Darwish, Wael A H Hegazy
Repurposing α -Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria. Antibiotics (Basel, Switzerland) 11 (2) (2022)
Kailey A Wyman, Adel S Girgis, Pragnakiran S Surapaneni, Jade M Moore, Noura M Abo Shama, Sara H Mahmoud, Ahmed Mostafa, Reham F Barghash, Zou Juan, Radha D Dobaria, Ahmad J Almalki, Tarek S Ibrahim, Siva S Panda
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach. Molecules (Basel, Switzerland) 27 (18) (2022)
Daniela Simona Cavalu, Samar S Elbaramawi, Ahmed G Eissa, Mohamed F Radwan, Tarek S Ibrahim, El-Sayed Khafagy, Bruno Silvester Lopes, Mohamed A M Ali, Wael A H Hegazy, Mahmoud A Elfaky
Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens. International journal of molecular sciences 23 (21) (2022)
Ahmad J Almalki, Tarek S Ibrahim, Sameh S Elhady, Wael A H Hegazy, Khaled M Darwish
Computational and Biological Evaluation of β -Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Abrar K Thabit, Khalid Eljaaly, Ayat Zawawi, Tarek S Ibrahim, Ahmed G Eissa, Samar S Elbaramawi, Wael A H Hegazy, Mahmoud A Elfaky
Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities. Microorganisms 10 (10) (2022)
Maan T Khayat, Tarek S Ibrahim, Khaled M Darwish, Ahdab N Khayyat, Majed Alharbi, El-Sayed Khafagy, Mohamed A M Ali, Wael A H Hegazy, Hisham A Abbas
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 10 (12) (2022)
Maan T Khayat, Tarek S Ibrahim, Khaled M Darwish, Ahdab N Khayyat, Majed Alharbi, El-Sayed Khafagy, Mohamed A M Ali, Wael A H Hegazy, Hisham A Abbas
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 10 (12) (2022)
Ahmad J Almalki, Tarek S Ibrahim, Ehab S Taher, Mamdouh F A Mohamed, Mahmoud Youns, Wael A H Hegazy, Amany M M Al-Mahmoudy
Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4 H )-Oxazolone-Based Sulfonamides. Molecules (Basel, Switzerland) 27 (3) (2022)
Momen M Askoura, Hisham A Abbas, Hadeel Al Sadoun, Wesam H Abdulaal, Amr Selim Abu Lila, Khaled Almansour, Farhan Alshammari, El-Sayed Khafagy, Tarek S Ibrahim, Wael A H Hegazy
Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients. Pathogens (Basel, Switzerland) 11 (1) (2022)
Maan T Khayat, Tarek S Ibrahim, Ahdab N Khayyat, Majed Alharbi, Moataz A Shaldam, Khadijah A Mohammad, El-Sayed Khafagy, Dalia A El-Damasy, Wael A H Hegazy, Hisham A Abbas
Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa . Microorganisms 10 (5) (2022)
Maan T Khayat, Tarek S Ibrahim, Khaled M Darwish, Ahdab N Khayyat, Majed Alharbi, El-Sayed Khafagy, Mohamed A M Ali, Wael A H Hegazy, Hisham A Abbas
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 10 (12) (2022)
Maan T Khayat, Hisham A Abbas, Tarek S Ibrahim, Ahdab N Khayyat, Majed Alharbi, Khaled M Darwish, Sameh S Elhady, El-Sayed Khafagy, Martin K Safo, Wael A H Hegazy
Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus . Biomedicines 10 (5) (2022)
Maan T Khayat, Tarek S Ibrahim, Khaled M Darwish, Ahdab N Khayyat, Majed Alharbi, El-Sayed Khafagy, Mohamed A M Ali, Wael A H Hegazy, Hisham A Abbas
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis. Microorganisms 10 (12) (2022)
Ibrahim M Salem, Samia M Mostafa, Ismail Salama, Osama I El-Sabbagh, Wael A H Hegazy, Tarek S Ibrahim
Design, synthesis and antitumor evaluation of novel pyrazolo[3,4- d ]pyrimidines incorporating different amino acid conjugates as potential DHFR inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2022)
Abrar K Thabit, Khalid Eljaaly, Ayat Zawawi, Tarek S Ibrahim, Ahmed G Eissa, Samar S Elbaramawi, Wael A H Hegazy, Mahmoud A Elfaky
Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa , Proteus mirabilis , and Serratia marcescens . Biology 11 (9) (2022)
Mahmoud A Elfaky, Abrar K Thabit, Khalid Eljaaly, Ayat Zawawi, Ahmed S Abdelkhalek, Ahmad J Almalki, Tarek S Ibrahim, Wael A H Hegazy
Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica . Antibiotics (Basel, Switzerland) 11 (11) (2022)
Riham M Bokhtia, Adel S Girgis, Tarek S Ibrahim, Fatma Rasslan, Eman S Nossier, Reham F Barghash, Rajeev Sakhuja, Eatedal H Abdel-Aal, Siva S Panda, Amany M M Al-Mahmoudy
Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Samar A El-Kalyoubi, Ehab S Taher, Tarek S Ibrahim, Mohammed Farrag El-Behairy, Amany M M Al-Mahmoudy
Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline-Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Nabil Abdulhafiz Alhakamy, Osama Abdelhakim Aly Ahmed, Tarek S Ibrahim, Hibah Mubarak Aldawsari, Khalid Eljaaly, Usama Ahmed Fahmy, Ahmed L Alaofi, Filippo Caraci, Giuseppe Caruso
Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Momen M Askoura, Ahmad J Almalki, Amr Selim Abu Lila, Khaled Almansour, Farhan Alshammari, El-Sayed Khafagy, Tarek S Ibrahim, Wael A H Hegazy
Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System. Microorganisms 9 (12) (2021)
Ahdab N Khayyat, Wael A H Hegazy, Moataz A Shaldam, Rasha A Mosbah, Ahmad J Almalki, Tarek S Ibrahim, Maan T Khayat, El-Sayed Khafagy, Wafaa E Soliman, Hisham A Abbas
Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens. Microorganisms 9 (5) (2021)
Mohammed W Al-Rabia, Nabil Abdulhafiz Alhakamy, Osama Abdelhakim Aly Ahmed, Khalid Eljaaly, Ahmed L Alaofi, Ahmed Mostafa, Hani Z Asfour, Ahmed A Aldarmahi, Khaled M Darwish, Tarek S Ibrahim, Usama Ahmed Fahmy
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies. Pharmaceutics 13 (3) (2021)
Tarek S Ibrahim, Azizah M Malebari, Mamdouh F A Mohamed
Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Tarek S Ibrahim, Mohamed M Hawwas, Azizah M Malebari, Ehab S Taher, Abdelsattar Mansour Omar Ebeid, Thikryat Neamatallah, Zakaria K Abdel-Samii, Martin K Safo, Yaseen A M M Elshaier
Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Momen R Fareed, Mai E Shoman, Mohammed I A Hamed, Mohamed Badr, Hanin A Bogari, Sameh S Elhady, Tarek S Ibrahim, Gamal El-Din A Abuo-Rahma, Taha Farouk Shehata Ali
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Tarek S Ibrahim, Israa A Seliem, Siva S Panda, Amany M M Al-Mahmoudy, Zakaria K M Abdel-Samii, Nabil Abdulhafiz Alhakamy, Hani Z Asfour, Mohamed Elagawany
An Efficient Greener Approach for N-Acylation of Amines in Water Using Benzotriazole Chemistry. Molecules (Basel, Switzerland) 25 (11) (2020)
Tarek S Ibrahim, Ehab S Taher, Ebtihal Samir, Azizah M Malebari, Ahdab N Khayyat, Mamdouh F A Mohamed, Riham M Bokhtia, Mohammed A AlAwadh, Israa A Seliem, Hani Z Asfour, Nabil Abdulhafiz Alhakamy, Siva S Panda, Amany M M Al-Mahmoudy
In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors. Molecules (Basel, Switzerland) 25 (14) (2020)
Azizah M Malebari, Tarek S Ibrahim, Ibrahim M Salem, Ismail Salama, Ahdab N Khayyat, Samia M Mostafa, Khaled M Darwish, Khaled M Darwish
The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Ali H Abu Almaaty, Yasmin M Abd El-Aziz, Nahed A Omar, Ahmed M Abdeen, Hala Afifi, Tarek S Ibrahim, Sameh S Elhady, Amgad I M Khedr
Antioxidant Property of the Egyptian Propolis Extract Versus Aluminum Silicate Intoxication on a Rat's Lung: Histopathological Studies. Molecules (Basel, Switzerland) 25 (24) (2020)
Zuhier A Awan, Usama Ahmed Fahmy, Shaimaa M Badr-Eldin, Tarek S Ibrahim, Hani Z Asfour, Mohammed W Al-Rabia, Anas Alfarsi, Nabil Abdulhafiz Alhakamy, Wesam H Abdulaal, Hadeel Al Sadoun, Nawal Helmi, Ahmad O Noor, Filippo Caraci, Diena M Almasri, Giuseppe Caruso
The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells. Pharmaceutics 12 (7) (2020)
Wael A H Hegazy, Maan T Khayat, Tarek S Ibrahim, Majed S Nassar, Muhammed A Bakhrebah, Wesam H Abdulaal, Nabil Abdulhafiz Alhakamy, Mahmoud M Bendary
Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa. Microorganisms 8 (9) (2020)
Israa A Seliem, Siva S Panda, Adel S Girgis, Yosra I Nagy, Riham F George, Walid Fayad, Nehmedo G Fawzy, Tarek S Ibrahim, Amany M M Al-Mahmoudy, Rajeev Sakhuja, Zakaria K M Abdel-Samii
Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids. Chemical biology & drug design 95 (2) (2019)

Tarek S Ibrahim.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tarek S Ibrahim